Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A new era in the treatment of systemic juvenile idiopathic arthritis.

Literature DB >> 23252530

A new era in the treatment of systemic juvenile idiopathic arthritis.

Christy Sandborg, Elizabeth D Mellins.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2012 PMID： 23252530 DOI： 10.1056/NEJMe1212640

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Juvenile idiopathic arthritis: what is the utility of ultrasound?

Authors: Hershernpal A S Basra; Paul D Humphries
Journal: Br J Radiol Date: 2017-04-06 Impact factor: 3.039

2. Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Authors: Yujuan Zhang; Saloni Gupta; Alexandra Ilstad-Minnihan; Sashi Ayyangar; Arielle D Hay; Virginia Pascual; Norman T Ilowite; Claudia Macaubas; Elizabeth D Mellins
Journal: Clin Immunol Date: 2018-06-19 Impact factor: 3.969

Review 3. Advances from clinical trials in juvenile idiopathic arthritis.

Authors: Daniel J Lovell; Nicola Ruperto; Edward H Giannini; Alberto Martini
Journal: Nat Rev Rheumatol Date: 2013-07-09 Impact factor: 20.543

Review 4. Juvenile idiopathic arthritis.

Authors: Alberto Martini; Daniel J Lovell; Salvatore Albani; Hermine I Brunner; Kimme L Hyrich; Susan D Thompson; Nicolino Ruperto
Journal: Nat Rev Dis Primers Date: 2022-01-27 Impact factor: 65.038

Review 10. Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

Authors: Anneleen Avau; Patrick Matthys
Journal: Pharmaceuticals (Basel) Date: 2015-11-25

A new era in the treatment of systemic juvenile idiopathic arthritis.

Review 1. Juvenile idiopathic arthritis: what is the utility of ultrasound?

2. Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Review 3. Advances from clinical trials in juvenile idiopathic arthritis.

Review 4. Juvenile idiopathic arthritis.

Review 5. IL-6 in inflammation, immunity, and disease.

Review 6. Advances in the treatment of rheumatoid arthritis.

Review 7. IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis.

Review 8. New frontiers in the treatment of systemic juvenile idiopathic arthritis.

Review 9. Juvenile Idiopathic Arthritis in the Era of International Cooperation.

Review 10. Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.